Participants 79 107 4
metastatic colorectal cancer
Participants 225 274 6
patients with metastatic colorectal cancer (mCRC)
Participants 571 674 7
279 previously untreated mCRC patients treated with capecitabine, oxaliplatin and bevacizumab (CAPOX-B)
Participants 1469 1482 6
mCRC patients
